# Safety and Tolerability of StroMel™ in Subjects with Moderate to Severe Osteoarthritis of the Knee Joint

> **NCT04750252** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Akan Biosciences, LLC** · enrollment: 20 (estimated)

## Conditions studied

- Osteo Arthritis Knee

## Interventions

- **BIOLOGICAL:** StroMel

## Key facts

- **NCT ID:** NCT04750252
- **Lead sponsor:** Akan Biosciences, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04750252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04750252, "Safety and Tolerability of StroMel™ in Subjects with Moderate to Severe Osteoarthritis of the Knee Joint". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04750252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*